MYX 1.59% $4.48 mayne pharma group limited

Ann: Change of Director's Interest Notice, page-15

  1. 418 Posts.
    lightbulb Created with Sketch. 138
    @Chartsshout he doesn't actually own those shares, can't sell them and derive benefit.
    They are performance rights and LTI incentive shares and is reflected due to accounting requirements.

    The only way for him to realise any benefit is for the share price to increase to meet the performance hurdles and be above the exercise price to be in the money.

    Below are the tiered performance conditions geared to gradually award consistent performance.

    As things stand the only tangible benefit SR has received since 2017 is the ~$1.3m salary and benefits.
    If anyone has information to the contrary..... please share the facts from a reliable source.


    https://hotcopper.com.au/data/attachments/3537/3537568-081e6b76e615bafc14d0c23c031ea00e.jpg

    https://hotcopper.com.au/data/attachments/3537/3537621-b9bed8440e159565a289b75d80408813.jpg

    https://hotcopper.com.au/data/attachments/3537/3537542-3edea5d3dbc63121e79e4c6386dd4054.jpg


    Below table illustrates the exercise price for the rights/options.
    As well as the history of vested shares.
    2019/2020 are within "easy" reach, however as per above they will also have to meet the performance hurdles.
    There are two schedules. 8% CAGR and 15% CAGR

    The only way for him to realise 100% of the benefit it for the share price to grow 15% per year for a period of 3 years minimum over the

    https://hotcopper.com.au/data/attachments/3537/3537554-c51ccd2e41002c53d87bca3eed3b627e.jpg



    If anyone has some more information to add - please do.
    Last edited by krugerrands: 02/09/21
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.